SIGA Technologies Inc. (SIGA)
6.39
0.07 (1.11%)
At close: Jan 22, 2025, 3:59 PM
6.39
0.00%
After-hours Jan 22, 2025, 04:41 PM EST
Company Description
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States.
Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus.
SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats.
The company was incorporated in 1995 and is headquartered in New York, New York.
SIGA Technologies Inc.
| Country | United States |
| IPO Date | Sep 10, 1997 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 45 |
| CEO | Dr. Diem Nguyen M.B.A., Ph.D. |
Contact Details
Address: 31 East 62nd Street New York, New York United States | |
| Website | https://www.siga.com |
Stock Details
| Ticker Symbol | SIGA |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001010086 |
| CUSIP Number | 826917106 |
| ISIN Number | US8269171067 |
| Employer ID | 13-3864870 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Diem Nguyen M.B.A., Ph.D. | Chief Executive Officer & Director |
| Daniel J. Luckshire CPA | Executive Vice President, Chief Financial Officer & Secretary |
| Herb Vloedman | Senior Vice President & Chief Information Officer |
| Dr. Dennis E. Hruby Ph.D. | Executive Vice President & Chief Scientific Officer |
| Lawrence R. Miller Esq., J.D. | General Counsel |
| Tove C. Bolken | Senior Vice President of Operations & Chief Supply Chain Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 13, 2024 | 8-K | Current Report |
| Dec 10, 2024 | 8-K | Current Report |
| Nov 08, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Nov 07, 2024 | 10-Q | Quarterly Report |
| Nov 07, 2024 | 8-K | Current Report |
| Oct 29, 2024 | 4 | Filing |
| Oct 24, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Oct 04, 2024 | 8-K | Current Report |
| Sep 23, 2024 | 8-K | Current Report |
| Sep 20, 2024 | 8-K | Current Report |